Atossa Genetics (NASDAQ: ATOS) announced that it has acquired from Besins Healthcare an exclusive license to Besins' patented gel formulation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE